From: Adverse events during intrahospital transport of critically ill patients: incidence and risk factors
Qualitative data | Univariate analysis | |||
---|---|---|---|---|
OR (95% CI) | p | OR (95% CI) | p | |
Treatments before transport | ||||
Dialysis | 0.84 (0.45-1.58) | NS | ||
Sedation | 1.48 (0.83-2.61) | NS | ||
Neuromuscular blockers use | 0.78 (0.3-2.02) | NS | ||
Norepinephrine before transport | 1.71 (0.86-3.39) | NS | ||
Dobutamine before transport | 1.11 (0.49-2.53) | NS | ||
Ventilatory mode before IHT | ||||
VAC | 1.09 (0.53-2.24) | NS | ||
BIPAP | 1.44 (0.52-3.99) | NS | ||
PSV | 0.74 (0.29-1.91) | NS | ||
FiO2 before IHT > 60% | 1.52 (0.77-2.99) | NS | ||
PEEP before IHT > 6 cmH2O | 2.16 (1.22-3.81) | 0.01 | 2.11 (1.17-3.8) | 0.01 |
Transport | ||||
More than four infusion pumps for transport | 1.07 (0.28-4.17) | NS | ||
Ventilatory mode change for transport | 1.14 (0.52-2.51) | NS | ||
Change of PEEP for transport | 0.76 (0.27-2.13) | NS | ||
Treatment modification for transport | 2.66 (1.44-4.91) | 0.002 | 2.81 (1.5-5.3) | 0.001 |
Sedation for transport | 3.05 (1.5-6.21) | 0.003 | NS | |
Neuromuscular blocker use for transport | 0.93 (0.29-2.98) | NS | ||
Fluid challenge for transport | 2.97 (0.92-9.54) | 0.087 | NS | |
Quantitative data | Without AE | With AE | Univariate analysis ( p ) | |
Patient data (Med (25th ,75th)) | ||||
Age (yr) | 57.5 [46–71.25] | 59.5 [50.75-69.5] | NS | |
SAPS II | 47 [34–61.5] | 49 [34–64] | NS | |
Transport data (average ± SD) | ||||
SOFA the day of transport | 5 [3–8.75] | NS | ||
MV duration before transport (days) | 4.5 [2–12.25] | 3.5 [2–9.75] | NS | |
No. of infusion pumps during transport | NS |